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Thus, it is biologically plausible that vitamin D deficiency-induced depression may, in part, be responsible for increased CV risk associated with low vitamin D levels. Additionally, the tendency for depressed patients to stay indoors and be physically inactive (both risk factors for vitamin D deficiency) may lead to low vitamin D levels, which, in turn, are associated with increased CV risk. 2 Although the study from Hoang et al 1 demonstrates that the association between low 25(OH)D levels was independent of physical activity, we were surprised that these Cooper Center Longitudinal Study data were also not corrected for precisely measured levels of cardiorespiratory fitness.
Vitamin D deficiency, besides being associated with depression, appears to increase the risk of developing inflammation, insulin resistance, diabetes, and atherosclerosis, and also activates the reninangiotensin-aldosterone system, which predisposes to hypertension and left ventricular hypertrophy. [3] [4] [5] All of these consequences of vitamin D deficiency, including depression, can adversely affect CV health and longevity ( Figure) . An abnormally low vitamin D level, as defined by a serum 25(OH)D level less than or equal to 20 ng/mL, is present in 42% of the overall American adult population, 82% of black individuals, and 69% of the Hispanic population. 3 The average 25(OH)D level in adults is 20 ng/mL 8 ; a long-term daily intake of an additional 100 IU of vitamin D will increase this level by only about 1 ng/mL. [3] [4] [5] Thus, supplementing the diet by the 600 to 800 IU daily as recommended by the Institute of Medicine's new guidelines 9 would be expected to raise adult Americans' mean vitamin D levels to 26 to 28 ng/mL, which is still in the insufficient range (Ͻ30 ng/mL). Recently, the Endocrine Society clinical practice guidelines 10 suggested doses of 1000 to 2000 IU of vitamin D 3 daily, which are much more likely to achieve a 25(OH)D level of at least 30 ng/mL.
Insufficient vitamin D causes musculoskeletal pain and weakness, and supplementing low 25(OH)D levels back into the normal ranges has been shown unequivocally to improve integrity and strength of bones and muscles and to reduce falls. 4, 5 Large randomized controlled trials are under way, and these should help to determine whether raising low vitamin D levels will also reduce risks for CV events, depression, and death. These results are not expected for several years (at least 3 years and possibly 5 years or more), and in the meanwhile it seems prudent to recommend a daily intake of 1500 to 2000 Predicting Recurrent Depression Using Vitamin D Levels?
To the Editor: I read the report of Hoang et al 1 on low 25-hydroxyvitamin D and depression with great interest. Of note, recently published guidelines on evaluation of vitamin D deficiency do not call for screening of persons with prior or current depression. 2 A plausible clinical application of the findings of this study-if confirmed, especially in multiracial cohortswould be to obtain 25-hydroxyvitamin D levels in patients with a history of depression and treat when indicated, in hope of preventing new episodes of depression.
Victor O. Kolade, MD

University of Tennessee College of Medicine
Chattanooga, TN In reply: We thank O'Keefe et al for their interest in our report on the association between serum hydroxyvitamin D and current depressive symptoms. 1 Lack of cardiorespiratory fitness (CRF) has been associated with depressive symptoms. For example, previous studies from the Aerobics Center Longitudinal Study found a significant inverse dose-response relationship between maximal CRF and depressive symptoms.
2,3 The current study focused on depressive symptoms and their relationship to serum hydroxyvitamin D from a psychiatric perspective. Physical activity has been used as a covariate by other similar studies exploring the relationship between vitamin D and depression. 4, 5 In our report, we controlled for physical activity, or exercise, which represents a modifiable behavior that was statistically significant in its inverse relationship to depressive symptoms in this study. 1 In sensitivity analyses that included CRF in the model, the relationship between vitamin D and depression was essentially unchanged.
We applaud O'Keefe et al's thoughtful review of the potential mechanisms linking depression, vitamin D, and cardiovascular disease. The idea that low vitamin D levels may be, in part, responsible for the association between depression and cardiovascular disorders is interesting and worthy of further investigation.
Kolade noted that guidelines for vitamin D deficiency do not call for screening vitamin D levels in the setting of current or prior depression. The idea of using vitamin D screening and, when necessary, supplementation to prevent depression relapse is very interesting and warrants further study.
MinhTu T. Hoang, BS
Department of Psychiatry University of Texas Southwestern Medical Center
Dallas, TX
